| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |